Cloning has sparked the human imagination for a long time, mostly because it sounds like something a screenwriter invented. But it is real, it has been happening for decades, and it shows up in more places than most people realize — medicine, agriculture, conservation, and competitive sports among them. It is also one of those topics where every new development tends to open up a fresh argument about whether we should be doing it at all.
At its core, cloning is the process of creating a genetically identical copy of a gene, cell, tissue, or living organism. Most people connect it to Dolly the sheep, but scientists had already been cloning frogs and other animals long before she arrived. Dolly was significant because she was cloned in 1996 at Scotland’s Roslin Institute from an adult body cell — something we’re told had not been done before, and that changed what people thought was biologically possible. The reasons scientists pursue cloning vary — advancing medical research, preserving valuable genetics, improving livestock breeding, protecting species on the edge of extinction, and studying how diseases are inherited. The counterarguments are also real — failed embryos, health problems in cloned animals, and the long-term risk of narrowing genetic diversity in ways that make entire populations more fragile.
The technology has moved well outside the laboratory. Argentina has become the global center for horse cloning, with biotechnology company Kheiron Biotech producing hundreds of cloned horses each year, according to The Wall Street Journal. Pet cloning has found its own market among people with money and a strong attachment to a particular animal. Barbra Streisand, Paris Hilton, and Tom Brady have all gone public about cloning their dogs. According to MIT Technology Review, the process runs around $50,000 and has become more accessible through companies like Colossal Biosciences, which recently acquired animal cloning specialist ViaGen Pets and Equine.
Conservation has also found uses for the technology. Scientists have used cloning to recreate the black-footed ferret from frozen cells collected decades ago and have experimented with species including the banteng, gaur, and Przewalski’s horse. The most dramatic attempt involved the Pyrenean ibex — which we’re told is the first extinct animal ever brought back through cloning — which survived only minutes after birth before dying from lung defects.
Then there is human cloning, wrapped in more rumor and speculation than almost any other area of science. Despite ongoing research and public speculation, there is currently no verified scientific evidence that a human clone has ever been successfully created. More than 70 countries have banned human reproductive cloning outright, with concerns centered on genetic selection, the commercialization of reproduction, and increased social inequality. Many countries, including the UK, Japan, Australia, Belgium, and South Korea, do permit therapeutic cloning for medical research under regulation. The United States has no single federal ban, leaving the question to a mix of state laws, funding restrictions, and institutional oversight that varies considerably depending on where you are.
Where cloning goes from here depends less on the science and more on the decisions made around it. The technology is capable of genuine good in medicine and conservation. It is also capable of raising problems that are hard to untangle once they exist. That tension is not going away, and how societies choose to manage it will shape what cloning ultimately means for all of us.
